iDOC: The Institute For Diabetes, Obesity, and Cardiovascular Disease
Member Sign in
Register Now! Forgot Password?
  • Home
  • CME
    • Audio
    • Video
    • Monographs
    • Patient
      Simulations
    • Webcast
      Archives
  • Resources
    • Articles and
      Editorials
    • Audio
    • Monographs
    • Patient
      Tools
    • Podcasts
    • Slide Decks
    • Video
    • Patient
      Simulations
    • Webcast
      Archives
  • Events
  • About iDOC
  • Contact Us
  • Resources
    • Articles and Editorials
    • Audio
    • Monographs
    • Patient Tools
    • Podcasts
    • Slide Decks
    • Video

    Video Presentations

    The Pathogenesis of Type 2 Diabetes The Potential Impact of Longer-Duration GLP-1 Therapies on T2DM Treatment Approaches and Patient Outcomes Incretin Therapy in Type 2 Diabetes Applied: Navigating and Making Changes in an Ever Changing Environment Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions? Inside the Doctor's Study: Addressing Cardiovascular Issues in Diabetes with Ralph DeFronzo Diabetes, Obesity and CVD: An Overview of the Related Physiology and Comprehensive Treatment Approaches Looking Beyond Glucose Control in Type 2 Diabetes: The Cardiovascular, Cardioprotective, and Weight Effects of GLP-1 Q&A Leveraging Weight Loss in the Treatment of Type 2 Diabetes Amylin and Pramlintide: Physiology and Its Role in the Treatment of Type 1 Diabetes, Type 2 Diabetes, and Obesity Clinical Approaches to Mimicking Normal Pancreatic Physiology Using Insulin and Amylin Replacement Therapy Biology of the Incretin Hormones Overcoming Injection Anxiety in Your Diabetes Patient Hypogonadism, Erectile Dysfunction and Diabetes: Heartfelt Problems The Metabolic Syndrome and Prediabetes: Can We Prevent Diabetes? Clinical Decision Making Around Incretin-Based Therapies: Re-examining the Safety Data -- Part 2 Clinical Decision Making Around Incretin-Based Therapies: Re-examining the Safety Data -- Part 1 Addressing Type 2 Diabetes at Its Core: Disease-Modifying Therapies Applied
    Highlights
    NEW! Evaluating Clinical Use of Long-Acting GLP-1 Therapy in Type 2 Diabetes Treatment Regimens - Dinner Programs NEW! Personalizing Patient Goals and Care in Type 2 Diabetes: One Size Does Not Fit All NEW! Managing Type 2 Diabetes: Consider What Is Important to the Patient NEW! Long-Acting GLP-1 Receptor Agonist Therapy: Improving Efficacy, Adherence, and Weight in T2DM NEW! Weighing In on the Beneficial Effects of GLP-1 Agonists: Assessing Cardiovascular Risk Reduction, Combination Therapy and Adherence NEW! Case Study: Avoiding Hypoglycemia and Increasing Adherence With Extended Release GLP-1 Therapy in Type 2 Diabetes NEW! Effective Use of Insulin Through the Progression of Type 2 Diabetes - Q & A


    iDOC
    © 2013 iDOC
  • Home
  • CME
  • Resources
  • Events
  • About iDOC
  • Privacy
  • Terms and Conditions
  • Contact Us